Skip to main content
Addgene

pcDNA3.1(+) - Hyperactive AID - T7 RNA Polymerase -UGI - T2A - tdTamato
(Plasmid #138610)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 138610 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pcDNA3.1(+)
  • Total vector size (bp) 10336
  • Vector type
    Mammalian Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert 1

  • Gene/Insert name
    Hyperactive AID
  • Alt name
    pcDNA3.1(+) - Hyperactive AID - T7 RNA Polymerase G645AQ744R-UGI - T2A - tdTomato
  • Insert Size (bp)
    585

Gene/Insert 2

  • Gene/Insert name
    T7 RNA Polymerase
  • Insert Size (bp)
    2646

Gene/Insert 3

  • Gene/Insert name
    tdTomato
  • Insert Size (bp)
    1428

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Hyperactive AID was cloned from pGH335_MS2-AID*Δ-Hygro obtained from Michael Bassik (Addgene plasmid # 85406)

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pcDNA3.1(+) - Hyperactive AID - T7 RNA Polymerase -UGI - T2A - tdTamato was a gift from Fei Chen (Addgene plasmid # 138610 ; http://n2t.net/addgene:138610 ; RRID:Addgene_138610)
  • For your References section:

    Efficient, continuous mutagenesis in human cells using a pseudo-random DNA editor. Chen H, Liu S, Padula S, Lesman D, Griswold K, Lin A, Zhao T, Marshall JL, Chen F. Nat Biotechnol. 2019 Dec 16. pii: 10.1038/s41587-019-0331-8. doi: 10.1038/s41587-019-0331-8. 10.1038/s41587-019-0331-8 PubMed 31844291